Effectiveness and Safety Evaluation of Embella (Deoxycholic Acid, by Espad Pharmed Co.) in Management of Submental Fat

Clinical trial NCT06509438 · COMPLETED

Trial details

NCT number: NCT06509438
Sponsor: Espad Pharmed
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Submental Fullness

Start date: 2023-04-10
Primary completion: 2024-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.